Tel Aviv / Zurich, 1 February 2017 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that the Board of Directors has accepted the resignation of Yuval Shaked, SHL’s CEO, and has appointed a search committee to look for a new CEO. Mr. Shaked has committed to continue his employment with SHL during the full six months notice period, to the extent required, to ensure a smooth transition with the new CEO, once elected.
SHL’s Chairman Uzi Blumensohn said: “On behalf of the Board of Directors of SHL, I thank Yuval for his fully committed service and for his contribution to SHL and I wish him good luck in the new challenges he has elected to accept. SHL’s strong Israeli and global leadership team is fully committed to continue and implement SHL’s streamlining program and strategic plans.”
Yuval Shaked said: “There is a new management team in place which will continue to implement the strategic and operational priorities we defined in the course of last year. I wish to thank Mr. Blumensohn, SHL board members, management and employees for their support and cooperation.”
Furthermore, SHL Telemedicine Ltd. announced today that Mr. Doron Steiger has stepped down from his position as board member with immediate effect. Under Israeli law, the fact that both Mr. Steiger and Mr. Harel, the newly appointed external director, also serve as board members in another public company, would no longer allow SHL to classify Mr. Steiger as a “non-dependent” director, nor to appoint him as a member of SHL’s audit and compensation committees.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit the web site at www.shl-telemedicine.com. For further information, please contact: Martin Meier-Pfister, IRF Communications, phone : +41 43 244 81 40, [email protected] For more information Click here
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit the web site at www.shl-telemedicine.com. For further information, please contact: Martin Meier-Pfister, IRF Communications, phone : +41 43 244 81 40, [email protected] For more information Click here
